Endobronchial Small Cell Lung Cancer Masquerading as Carcinoid Tumour in a Young Female: A Case Report
OD05-OD07
Correspondence
Mrinmayee Vijay Mayekar,
101, Jai Gurudev CHS, Plot 6, Sector 1, Sanpada, Navi Mumbai, Wardha-400705, Maharashtra, India.
E-mail: m.mayekar94@gmail.com
Bronchial Carcinoid Tumours, also known as BCTs, are remarkable neuroendocrine malignancies that can denature chemical compounds with biological activity. The phrase “bronchial adenomas” was once used to refer to BCTs; however, this nomenclature is no longer utilised because BCTs are neither glandular nor invariably benign. Instead, the term “Bronchial Cystic Tumours” is used to refer to BCTs in this context. They are normally a neoplasm that expands slowly and displays a variety of behaviours, yet they are also capable of expanding rapidly and being significantly more aggressive in general. Despite the fact that smoking is a significant risk factor for Small Cell Lung Cancer (SCLC), which is a more severe form of lung cancer than carcinoid, surgery is still the treatment of choice for carcinoid tumours, while chemoradiation and chemotherapy are the only options for patients with stage four SCLC. Here, the authors discuss the case of a 30-year-old young female patient who was erroneously diagnosed with endobronchial carcinoid, which turned out to be SCLC. Because of the significant connection between smoking and SCLC, malignancies are not usually seen in young females. The relevant patient’s investigations were consistent with small cell carcinoma of the lung. Immunohistochemistry for CD56 and synaptophysin turned out to be positive. The patient received six cycles of chemotherapy with an injection of Cisplatin and an injection of Etoposide every three weeks. She was followed-up after three months and did have symptomatic relief.